Boosters raise protection against death from Omicron to 95% in 50-plus

1/27/2022 10:15:00 PM

Covid boosters increase protection against death from the Omicron variant to 95% in people aged 50 and over

Covid boosters increase protection against death from the Omicron variant to 95% in people aged 50 and over

Covid boosters increase protection against death from the Omicron variant to 95% in people aged 50 and over, the UK Health Security Agency (UKHSA) said on Thursday.

How rediscovering your inner child could help you work better Moderna jabs offer 90-95% effectiveness against hospitalisation up to 9 weeks after the booster.Register for free to continue reading Registration is a free and easy way to support our truly independent journalism By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists register Please enter a valid email Please enter a valid email Password Must be at least 6 characters, include an upper and lower case character and a number Must be at least 6 characters, include an upper and lower case character and a number Must be at least 6 characters, include an upper and lower case character and a number First name Please enter your first name Special characters aren’t allowed Please enter a name between 1 and 40 characters Last name Please enter your last name Special characters aren’t allowed Please enter a name between 1 and 40 characters Select your year of birth 2004.Scientists invent wearable Covid detector that can tell how risky your workplace is Its stealth nickname comes from one of its key differences with the original Omicron.Moderna Inc says it has started a mid-stage study, testing a booster dose of its Covid-19 vaccine specifically designed to target the Omicron variant, a day after rival Pfizer Inc launched a similar trial.

Dr Mary Ramsay, Head of Immunisation at UKHSA, said: “The evidence is clear – the vaccine helps to protect us all against the effects of COVID-19 and the booster is offering high levels of protection from hospitalisation and death in the most vulnerable members of our society.” Initial analysis of vaccine effectiveness against the Omicron sublineage called BA.2 found a similar level of protection against symptomatic disease, the UKHSA said.It means that while PCR tests will still spot if someone has this version of Covid-19, the samples would need to be sent for further lab analysis to determine if someone had ‘stealth’.“After two doses effectiveness was 9% and 13% respectively for BA.1 and BA.It would test the booster in individuals who received only the two-dose primary series of Moderna’s original vaccine, mRNA-1273, and also in those who received the primary series and a booster dose of the sam.

2, after 25+ weeks,” the UKHSA said.Dr Tom Peacock, one of the first virologists to raise the alarm over Omicron, said “Even with slightly higher transmissibility this absolutely is not a Delta to Omicron change, and instead is likely to be slower and more subtle.“This increased to 63% for BA.1 and 70% for BA.2 from two weeks following a.' The scientist, from Imperial College London, told the Daily Mail : “Very early observations from India and Denmark suggest there is no dramatic difference in severity.

Read more:
Evening Standard »
Loading news...
Failed to load news.

Two new cases of Omicron sub-variant confirmed in CaliforniaTwo new cases of Omicron sub-variant BA2 confirmed in California Just in time for a new improved booster Not real

What we know so far about ‘stealth Omicron’, new sub-variant BA.2What we know so far about ‘stealth Omicron’, new sub-variant BA.2 😷

Covid news live: Johnson vows to fight on despite lockdown party outrage; Moderna begins trial of Omicron-specific booster shotBritish PM braces for “partygate” report as England scraps indoor mask requirements and vaccine passports; Moderna follows Pfizer in launching trial to target Omicron Moderna may be starting to test an Omicron vaccine but BioNTech went into production earlier this month. Keep up.

Pfizer begins clinical trials for Omicron-specific COVID-19 vaccinePfizer has started clinical trials for a Covid shot tailored to the Omciron variant. The company expects the jab to become available in March, but some say the shot is coming too late.

'Sister’ sub-variant will overtake Omicron in a month - but it’s 'as mild'THE ‘sister’ sub-variant of Omicron is set to overtake the original within a month. It is thought to be able to spread slightly faster – but currently isn’t believed to be a… Fascinating What variant of the Flu or the common cold are we on? If I catch both is it insest

Out-of-control SpaceX rocket on collision course with the moonFalcon 9 booster was originally launched from Florida in 2015 to deploy Deep Space Climate Observatory Mas gente DontLookUp Like BorisJohnson Cabinet Conservatives Ministers Except SEEMs BorisJohnson Is Going To Take Can FOR Top Self Ministers Chronic Incompetence Peace Meal 🥘 Hanging Him Out To Dry SkyNews BBCBreaking bbclaurak Dominic2306 FT TheGardianNews